{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T22:05:55Z","timestamp":1751753155618},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,29]]},"DOI":"10.7759\/cureus.46181","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T09:41:41Z","timestamp":1695980501000},"source":"Crossref","is-referenced-by-count":2,"title":["Methodology for Isolation of miRNA From the Serum of Women Investigated for Pre-eclampsia"],"prefix":"10.7759","author":[{"given":"Flora","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Grammatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis &amp; management recommendations for international practice","volume":"13","author":"Brown MA","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, et al.. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis &amp;amp; management recommendations for international practice. Pregnancy Hypertens. 2018, 13:291-310. 10.1016\/j.preghy.2018.05.004","journal-title":"Pregnancy Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsgi.2004.03.003","article-title":"Placental oxidative stress: from miscarriage to preeclampsia","volume":"11","author":"Burton GJ","year":"2004","unstructured":"Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004, 11:342-52. 10.1016\/j.jsgi.2004.03.003","journal-title":"J Soc Gynecol Investig"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S142732","article-title":"Placenta-derived exosomes: potential biomarkers of preeclampsia","volume":"12","author":"Pillay P","year":"2017","unstructured":"Pillay P, Moodley K, Moodley J, Mackraj I. Placenta-derived exosomes: potential biomarkers of preeclampsia. Int J Nanomedicine. 2017, 12:8009-23. 10.2147\/IJN.S142732","journal-title":"Int J Nanomedicine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton GJ","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019, 366:l2381. 10.1136\/bmj.l2381","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmq007","article-title":"An immunological insight into the origins of pre-eclampsia","volume":"16","author":"Laresgoiti-Servitje E","year":"2010","unstructured":"Laresgoiti-Servitje E, G\u00f3mez-L\u00f3pez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010, 16:510-24. 10.1093\/humupd\/dmq007","journal-title":"Hum Reprod Update"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"Rana S","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019, 124:1094-112. 10.1161\/CIRCRESAHA.118.313276","journal-title":"Circ Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub2","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley L","year":"2007","unstructured":"Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007, CD004659. 10.1002\/14651858.CD004659.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001059.pub5","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","volume":"10","author":"Hofmeyr GJ","year":"2018","unstructured":"Hofmeyr GJ, Lawrie TA, Atallah \u00c1N, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018, 10:CD001059. 10.1002\/14651858.CD001059.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004227.pub3","article-title":"Antioxidants for preventing pre-eclampsia","volume":"2008","author":"Rumbold A","year":"2008","unstructured":"Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev. 2008, 2008:CD004227. 10.1002\/14651858.CD004227.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","unstructured":"PLGF-based testing to help diagnose suspected preterm pre-eclampsia Diagnostics guidance [DG49]. (2022). Accessed. September 29, 2023: https:\/\/www.nice.org.uk\/guidance\/dg49."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:plgf ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler H","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, et al.. Predictive value of the sFlt-1:plgf ratio in women with suspected preeclampsia. N Engl J Med. 2016, 374:13-22. 10.1056\/NEJMoa1414838","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41800-2","article-title":"Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications","volume":"9","author":"Patel GK","year":"2019","unstructured":"Patel GK, Khan MA, Zubair H, Srivastava SK, Khushman M, Singh S, Singh AP. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci Rep. 2019, 9:5335. 10.1038\/s41598-019-41800-2","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1662","article-title":"microRNA-based diagnostic and therapeutic applications in cancer medicine","volume":"12","author":"Sempere LF","year":"2021","unstructured":"Sempere LF, Azmi AS, Moore A. microRNA-based diagnostic and therapeutic applications in cancer medicine. Wiley Interdiscip Rev RNA. 2021, 12:e1662. 10.1002\/wrna.1662","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7637","article-title":"Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies","volume":"18","author":"Zhong Y","year":"2019","unstructured":"Zhong Y, Zhu F, Ding Y. Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies. Exp Ther Med. 2019, 18:826-32. 10.3892\/etm.2019.7637","journal-title":"Exp Ther Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3367","article-title":"Placenta\u2011associated serum exosomal miR\u2011155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells","volume":"41","author":"Shen L","year":"2018","unstructured":"Shen L, Li Y, Li R, et al.. Placenta\u2011associated serum exosomal miR\u2011155 derived from patients with preeclampsia inhibits eNOS expression in human umbilical vein endothelial cells. Int J Mol Med. 2018, 41:1731-9. 10.3892\/ijmm.2018.3367","journal-title":"Int J Mol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.12.045","article-title":"Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies","volume":"200","author":"Zhu XM","year":"2009","unstructured":"Zhu XM, Han T, Sargent IL, Yin GW, Yao YQ. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009, 200:661.e1-7. 10.1016\/j.ajog.2008.12.045","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02227-w","article-title":"Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities","volume":"18","author":"Yang H","year":"2020","unstructured":"Yang H, Ma Q, Wang Y, Tang Z. Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities. J Transl Med. 2020, 18:32. 10.1186\/s12967-020-02227-w","journal-title":"J Transl Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2012.00202","article-title":"A high-throughput method for Illumina RNA-Seq library preparation","volume":"3","author":"Kumar R","year":"2012","unstructured":"Kumar R, Ichihashi Y, Kimura S, et al.. A high-throughput method for Illumina RNA-Seq library preparation. Front Plant Sci. 2012, 3:202. 10.3389\/fpls.2012.00202","journal-title":"Front Plant Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2015.05.003","article-title":"RNA biomarkers to facilitate the identification of aggressive prostate cancer","volume":"45","author":"Pellegrini KL","year":"2015","unstructured":"Pellegrini KL, Sanda MG, Moreno CS. RNA biomarkers to facilitate the identification of aggressive prostate cancer. Mol Aspects Med. 2015, 45:37-46. 10.1016\/j.mam.2015.05.003","journal-title":"Mol Aspects Med"},{"key":"ref20","unstructured":"Plasma\/Serum Exosome Purification and RNA Isolation Midi Kit. (2023). Accessed. September 29, 2023: https:\/\/norgenbiotek.com\/product\/plasmaserum-exosome-purification-kit."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67935-1","article-title":"Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV\/HCV coinfected patients","volume":"10","author":"Mart\u00ednez-Gonz\u00e1lez E","year":"2020","unstructured":"Mart\u00ednez-Gonz\u00e1lez E, Brochado-Kith \u00d3, G\u00f3mez-Sanz A, et al.. Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV\/HCV coinfected patients. Sci Rep. 2020, 10:11140. 10.1038\/s41598-020-67935-1","journal-title":"Sci Rep"},{"key":"ref22","unstructured":"Agilent RNA 6000 Pico Kit. (2023). Accessed. September 29, 2023: https:\/\/www.agilent.com\/en\/product\/automated-electrophoresis\/bioanalyzer-systems\/bioanalyzer-rna-kits-reagents\/bioana...."},{"key":"ref23","unstructured":"TruSeq Small RNA Sample Prep Kit. (2023). Accessed. September 29, 2023: https:\/\/emea.illumina.com\/products\/by-type\/sequencing-kits\/library-prep-kits\/truseq-small-rna.html."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum microRNAs are promising novel biomarkers","volume":"3","author":"Gilad S","year":"2008","unstructured":"Gilad S, Meiri E, Yogev Y, et al.. Serum microRNAs are promising novel biomarkers. PLoS One. 2008, 3:e3148. 10.1371\/journal.pone.0003148","journal-title":"PLoS One"},{"key":"ref25","unstructured":"Quality scores for next-generation sequencing. (2011). Accessed. September 29, 2023: https:\/\/www.illumina.com\/documents\/products\/technotes\/technote_Q-Scores.pdf."},{"key":"ref26","unstructured":"miRNeasy Serum\/Plasma Advanced Kit. (2021). Accessed. September 26, 2023: https:\/\/www.qiagen.com\/us\/resources\/resourcedetail?id=20e0ddd1-ad97-43ef-9edf-eef6a6d02a1d&amp;lang=en."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192519-methodology-for-isolation-of-mirna-from-the-serum-of-women-investigated-for-pre-eclampsia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:53Z","timestamp":1707509333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192519-methodology-for-isolation-of-mirna-from-the-serum-of-women-investigated-for-pre-eclampsia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.46181","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}